Jeff Held
Conseiller Juridique Général chez DECIPHERA PHARMACEUTICALS, INC.
Profil
Jeffrey M.
Held is currently the General Counsel & Senior Vice President at Deciphera Pharmaceuticals, Inc. He previously worked as the Secretary & General Counsel at Proteostasis Therapeutics, Inc., Principal at HeartWare International LLC, and Secretary & General Counsel at PeopleFluent, Inc. Mr. Held completed his undergraduate degree at Tufts University and his graduate degree at Fordham University School of Law.
Postes actifs de Jeff Held
| Sociétés | Poste | Début |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/01/2018 |
Anciens postes connus de Jeff Held
| Sociétés | Poste | Fin |
|---|---|---|
PeopleFluent, Inc.
 PeopleFluent, Inc. Packaged SoftwareTechnology Services PeopleFluent, Inc. provides Software-as-a-Service talent management solutions. It offers PeopleFluent Mirror Suite that integrates video and social technologies into various talent applications; PeopleFluent Colossus, a data integration cloud service that connects talent data and applications; Recruitment Software, a talent acquisition solution that allows clients to make informed hiring decisions; and Performance Management that allows clients to improve business results, develop employees, and retain key staff. The company was founded by Todd Hayes Loofbourrow in 1997 and is headquartered in Waltham, MA. | Conseiller Juridique Général | 01/01/2016 |
| HEARTWARE INTERNATIONAL INC | Corporate Officer/Principal | 01/01/2011 |
| PROTEOSTASIS THERAPEUTICS, INC. | Conseiller Juridique Général | - |
Formation de Jeff Held
| Tufts University | Undergraduate Degree |
| Fordham University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
HeartWare International LLC
 HeartWare International LLC Medical SpecialtiesHealth Technology HeartWare International LLC is a medical device company, which engaged in the development and manufacturing of miniaturized implantable heart pumps or ventricular assist devices to treat patients suffering from advanced heart failure. The company was founded on July 29, 2008 and is headquartered in Framingham, MA. | Health Technology |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
PeopleFluent, Inc.
PeopleFluent, Inc. Packaged SoftwareTechnology Services PeopleFluent, Inc. provides Software-as-a-Service talent management solutions. It offers PeopleFluent Mirror Suite that integrates video and social technologies into various talent applications; PeopleFluent Colossus, a data integration cloud service that connects talent data and applications; Recruitment Software, a talent acquisition solution that allows clients to make informed hiring decisions; and Performance Management that allows clients to improve business results, develop employees, and retain key staff. The company was founded by Todd Hayes Loofbourrow in 1997 and is headquartered in Waltham, MA. | Technology Services |
Deciphera Pharmaceuticals, Inc.
 Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. The company was founded by Peter A. Petillo and Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
